Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The manufacturer, Eli Lilly, is enrolling patients with type 2 diabetes to compare the effect of retatrutide with semaglutide in adult patients with type 2 diabetes and poor glycemic control with metformin and with or without SGLT2 inhibitors
Treatment typically begins with a low starting dose , which is gradually increased every 14 weeks (depending on the agent) until the target maintenance dose is reached or the maximum tolerated dose is achieved
Talk to your healthcare provider about any questions or concerns you might have
GLP-1 Complete Next-generation weight management solution to reduce food cravings, promote feeling full more quickly, and keep you feeling satisfied longer by activating multiple GLP-1 receptors
Consult a qualified healthcare provider before beginning any peptide protocol
-:
US$ 28.53
US$ 21.39
US$ 29.71
US$ 24.48
US$ 23.94
